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and persisted following interventions, and 2) the impact of inter-
ventions on quality, and patient drug costs from a payer per-
spective. METHODS: Before-after study with comparison group
design. Medicaid prescription claims data were compared for
three months prior to and following the intervention. RESULTS:
In total, 253 nursing homes, 110 consultant pharmacists, and
6344 patients participated in the study arm, with 5160 patients
remaining at the end of the follow-up period. At baseline, study
group patients used an average of 9.7 prescriptions per month,
costing the NC Medicaid program $517(USD). There were 5918
recommendations offered for 3262 patients, or an average of
1.58 per patient. At least one proﬁle-related pharmacist inter-
vention was implemented for 72% of patients, about half involv-
ing a switch to a lower cost drug. Two of ﬁve alert categories
had highly signiﬁcant reductions in alert persistence of 10.8%
and 29.7% respectively versus 0.7% and 14.1% in the compar-
ison group. Drug costs for study group patients were $57 
lower than comparison group patients at follow-up (p < 0.05).
CONCLUSIONS: A supplemental program of medication
reviews for targeted NH patients resulted in a reduction in the
persistence of PDTP alerts and was cost beneﬁcial based solely
on drug cost savings. This intervention may be a model for future
medication therapy management services provided by prescrip-
tion drug plans under Medicare for patients in long-term-
care settings.
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OBJECTIVE: This research was performed to analyze selected
socioeconomic and clinical factors relating to both physicians
and patients associated with physicians’ prescribing of expensive
medications and medications with abuse potential side effects 
for treatment of sleep difﬁculties in a nationally representative
sample of outpatient physician visits in the United States.
METHODS: A multivariate logistic regression method was used
to analyze the 1996–2001 National Ambulatory Medical Care
Survey data to determine the patient and physician factors asso-
ciated with a prescription for expensive medication and medica-
tions with abuse potential side effects in outpatient settings.
RESULTS: From 1996 to 2001, about 94.6 million sleep-
difﬁculty related visits were made to outpatient physician ofﬁces
in the United States. Forty eight percent (45 million) of sleep-
difﬁculty related visits received prescription for medication
therapy only. Patients over 65 years of age were 44% less likely
(OR: 0.56, 95% CI: 0.35–0.90) to receive an expensive medica-
tion prescriptions than patients aged 18–34 years (reference
group). Hispanic patients were 56% less likely to receive an
expensive medication prescription than Non-Hispanic patients
during their visits (OR: 0.44, 95% CI: 0.22–0.88). Male patient
visits were 39% less likely than female patient visits to result in
receipt of medication with abuse potential among patient visits
receiving medication therapy (OR: 0.61, 95% CI: 0.45–0.81). In
addition, patients with mental co-morbidities were 80% more
likely to be associated with receipt of a prescription of medica-
tions with abuse potential than patients with no mental co-
morbidities (OR: 1.80, 95% CI: 1.31–2.47). CONCLUSIONS:
This study indicated that patient’s age and ethnicity inﬂuence
physician prescribing of expensive medications for treatment of
sleep difﬁculties. In addition, increased probability of receipt of
medication with abuse potentials in female gender is of concern,
when safer alternative medications with lower abuse potentials
are easily available.
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OBJECTIVES: To understand and quantify the consumers’
choice and preferences for the heavily discussed and politically
promoted introduction of gatekeeper models in primary care as
a measure of effective cost containment. Furthermore, to explore
which of the patients’ segments could be addressed by which
value proposition, which design elements to use and what kind
of incentive structures to create. METHODS: Applying stochas-
tic methods, a representative sample of 3024 people from the
health insured population was taken and segmented according
to four basic dimensions (age, gender, income, and insurance
status). About 1000 interviews were performed in a telephone
survey. Participants were asked 10 questions about their knowl-
edge on primary care and gatekeeper models. Other questions
addressed aspects such as design elements of potential gatekeeper
models, parameters for the interviewee’s choice on a potential
family doctor, demands on the quality of a family doctor, and
incentive structures. RESULTS: The participants showed differ-
entiated answer proﬁles. Older and currently ill people were 
signiﬁcantly better informed concerning gate keeper models in
primary care. In total, 88% already go to their family doctor and
60% use their family doctor as the primary address and would
participate at a gatekeeper model without extra incentives. The
demands on family doctors are dependent on age and gender.
Neighbourhood and personal experience as well as quality and
service level are key factors. CONCLUSIONS: It can be con-
cluded that even without being well informed and without
explicit incentive structures, the insured already behave accord-
ing to the principles of primary care and gatekeeper models, 
limiting the political effect of reorganising patient streams 
in ambulatory care. Furthermore, insurance companies should
investigate consumers’ choices in primary care before setting up
sophisticated incentive systems.
Methods and Concepts in Patient-Oriented Research
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OBJECTIVES: Extensive longitudinal data are required to char-
acterize the outcomes of serious mental disorders. Statistical
methods for proﬁling individual differences in clinical and social
outcomes, and the impact of treatment have expanded over the
past decade, are now implemented in user friendly software. Our
aim was to characterize individual trajectories in patient-rated
quality of life scores recorded over two years. METHODS: The
sample comprised 10,000 outpatients with schizophrenia partic-
ipating in the Schizophrenia Outpatient Health Outcomes
(SOHO) observational study of health outcomes of antipsychotic
treatment which was conducted in 10 European countries.
SOHO enrolled schizophrenia outpatients who were initiating 
or changing their antipsychotic medication. The outcome was
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derived from the ﬁve dimensions of the EQ-5D (mobility, self-
care, usual activities, pain/discomfort, and anxiety/depression).
A single utility score on an interval metric was provided by the
application of health state evaluations. Individual differences in
clinical outcome trajectories were modeled using latent curve
models that captured linear and non-linear trends over time for
SOHO participants. Model estimation used Maximum Likeli-
hood methods in Mplus software and therefore enabled inclu-
sion of missing data under a Missing At Random (MAR)
assumption. RESULTS: EQ-5D utility scores could not be 
adequately summarised by simple linear models over two years.
Instead models allowing for curvilinear trajectories were
required. The fastest change in EQ-5D utility scores occurred in
the six months after medication initiation or change. Some indi-
viduals with later relapses were also identiﬁed by turning points
in their outcome trajectory. CONCLUSIONS: New statistical
methods for latent growth modeling are useful tools for dis-
playing and modeling individual variations in clinical and social
outcomes, including self-rated quality of life, in schizophrenia
patients. In future work we hope to relate these proﬁles to pat-
terns of medication change.
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OBJECTIVES: LOGIC (Longitudinal Outcomes study of Gas-
trointestinal symptoms in Canada) and ILOS (Irritable bowel
syndrome Longitudinal Outcomes Study) are two ongoing phar-
macoepidemiologic studies of patients with irritable bowel syn-
drome with constipation or alternating constipation/diarrhea
(IBS-C or IBS-A) across Canada and the US, respectively. The
purpose was to develop and validate a self-report questionnaire
that measures severity of IBS symptoms in patients with IBS-C
and IBS-A. METHODS: The IBS patient’s symptoms question-
naire was a 15-item questionnaire that measured frequency,
intensity, and distress/bother associated with the following IBS
symptoms: constipation, gas, abdominal pain/discomfort, bloat-
ing, and diarrhea. All items were measured on a 0 to 5-point
scale except for the frequency items from the ILOS study, which
were measured on a 0 to 4-point scale. To explore the question-
naire items, a principal component analysis (PCA) was per-
formed. Correlations between the baseline severity scores and the
baseline IBS-QOL overall scores were calculated. RESULTS: To
date, 1557 subjects have provided the IBS severity of symptoms
questionnaire at baseline for LOGIC. The PCA showed that
three components provide a good summary of the data, with the
1st, 2nd, and 3rd components accounting for 37%, 20%, and
13% of the total variability in the data, respectively. Similar PCA
results were observed for the 380 subjects who provided the
ILOS questionnaire. For both studies, the ﬁrst component
approximates a simple average of scores for items of all symp-
toms excluding diarrhea. The resulting Severity Score signiﬁ-
cantly correlates with the IBS-QOL total score with r = -0.549
(p < 0.001) for LOGIC and r = -0.468 (p < 0.001) for ILOS.
CONCLUSIONS: Although more extensive testing of the ques-
tionnaire is required, the IBS Severity questionnaire seems too
efﬁciently and comprehensively measure patient severity of IBS
symptoms. The Severity Score appears to be an effective measure
of overall severity for subjects with IBS-C or IBS-A.
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OBJECTIVES: Interventions that increase compliance with med-
ication may improve outcomes in schizophrenia, but need to be
targeted on groups at high risk for non-adherence behaviours.
The aims of this study were 1) to deﬁne latent adherence classes,
one year after antipsychotic medication change or initiation, and
2) to examine predictors of class membership from clinical and
treatment variables recorded one year earlier. METHODS:
Latent class analysis was applied to indicators of compliance
behaviour twelve months after new antipsychotic medication
was initiated or existing medication changed. The sample com-
prised 1,736 patients with schizophrenia sampled from the seven
drug cohorts participating in the Schizophrenia Outpatient
Health Outcomes (SOHO) observational study of health out-
comes of antipsychotic treatment (n = 10,218). RESULTS: Over
three quarters of the SOHO sample were highly compliant 
with antipsychotic medication. 19% were identiﬁed by the 
model as non-adherent. In addition to treatment cohort, drug
abuse (adj OR = 1.69, 95% CI 1.07–2.65), alcohol abuse (adj
OR = 1.61, 95% CI 1.03–2.53) or hospital admission (adj OR
= 1.97 95% CI 1.43–2.71) prior to study entry predicted non-
adherence class membership one year later. CONCLUSIONS:
Latent classiﬁcation analyses identiﬁed a patient group at risk
for poor medication compliance that could be targeted with
interventions to increase adherence behaviours. Further reﬁne-
ments of this classiﬁcation may identify a continuum of compli-
ance behaviours.
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OBJECTIVE: The Q-TWiST (Quality-Adjusted Time Without
Symptoms or Toxicity) method compares treatments for time
spent in clinically different health states that vary by patient
utility (toxicity, symptom-free period and disease relapse).
Kaplan-Meier or Cox model-based estimators of transition times
between states are generated separately to account for censoring
and loss to follow-up. Q-TWiST is then calculated as a weighted
sum of mean health state durations and its variance is calculated
using the bootstrap method. The methodology is well-accepted
in oncology research, but has been used infrequently in other
therapeutic areas. Application is restricted to time-sensitive out-
comes and to well-controlled clinical trials. METHODS: We
present a new approach to calculate Q-TWiST and its variance
using a repeated measures framework in a multivariate failure
time regression model (Wei, Lin, Weissfeld, 1989). First, a single
likelihood function that incorporates multiple events is derived
and event-speciﬁc parameters are then estimated simultaneously
by maximizing the likelihood function. Once the parameter esti-
mates are obtained, the robust variance-covariance matrix is
easily computed, incorporating within-patient correlations of
event times. The utility-weighted Q-TWiST and its variance are
derived by the delta method utilizing the estimated parameters
